Agere Expands cGMP Spray Dry Manufacturing Capabilities

Published: Nov 06, 2012

BEND, Ore.--(BUSINESS WIRE)--Agere Pharmaceuticals, Inc., a leading oral solubilization-focused contract research and manufacturing organization (CRO/CMO), announced today that it has added the capability to support clients entering Phase IIb clinical trials with cGMP manufacturing. The new capacity extends the services to pharmaceutical companies that currently partner with Agere for formulation development to improve oral bioavailability of their BCS II and IV compounds. By expanding cGMP manufacturing services, Agere now offers its clients one-stop-shopping from concept development through manufacturing for advanced clinical trials.

Back to news